Home⇛College of Dentistry Research Journal⇛vol. 8 no. 1 (2023)

Personal and Medical Reasons Influencing Willingness to Receive Covid-19 Booster among Dentistry Students

Ricklyn S. Belleca | Francea Lauren T. Castillo | Mikaella M. Catapang | Nicaella Charizze Guico | Jerome R. Magnaye | Smile Y. Mojica

Discipline: Dentistry

 

Abstract:

Due to the recent increase in the incidence of COVID-19 cases, it is significant to measure the matter of influencing willingness to receive booster shot against COVID-19 in this period. Therefore, this study pivots around on the personal and medical reasons influencing willingness to receive booster shot against the virus among the 5th year dentistry students from the Lyceum of the Philippines University - Batangas. The researcher made use of a quantitative research method to 35 respondents using the non-probability sampling method technique. Based on the significant findings, most dentistry students were mostly young, female, no issues on type of comorbidities, had Pfizer for both I st dose and 2nd dose, with common side effects of either the 1st dose or 2nd dose (fever, head or body aches, sore arm), and not infected before and after vaccination. The respondents agreed that the personal reasons that influenced their willingness to receive COVID-19 booster are they wanted to protect themselves and those around them, getting the booster shot is a responsibility to the community, they trusted the pharmaceutical firms that manufactured the booster, believed the booster can reduce the need for lockdowns, quarantine, work permits, and travel restrictions, considered the booster dose as the most efficient way to overcome COVID-19 pandemic, and their trusted health care provider advised them to take the booster shot. Majority of the dentistry students agreed that the medical reasons that influenced their willingness to receive COVID-19 booster were booster will aid in the development of herd immunity, effectiveness of the COVID-19 booster is reliable because the developers follow a step-by-step process, and it is still beneficial to receive a booster after recently receiving the primary doses because the protection declines over time. The personal reasons and medical reasons were both significant in willingness to receive COVID-19 booster dose. The difference between the reasons influencing willingness to receive booster shot when grouped according to the profile are not significant. The 2nd dose received is the only variable that shows significant difference on the willingness to receive booster shot against COVID-19. Majority of the dentistry students are willing to receive COVID-19 booster dose.



References:

  1. Adams, K., Rhoads, J. P., Surie, D., Gaglani, M., Ginde, A. A., McNeal, T., Talbot, H. K., Casey, J. D., Zepeski, A., Shapiro, N. I., Gibbs, K. W., Files, D. C., Hager, D. N., Frosch, A. E., Exline, M. C., Mohamed, A., Johnson, N. J., Steingrub, J. S., Peltan, I. D., . . . Self, W. H. (2022). Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. BMJ, e072065. https://doi.org/10.1136/bmj-2022-072065
  2. Ahluwalia, S. C., Gross, C. P., Chaudhry, S. I., Ning, Y. M., Leo-Summers, L., Van Ness, P. H., & Fried, T. R. (2011). Impact of Comorbidity on Mortality Among Older Persons with Advanced Heart Failure. Journal of General Internal Medicine, 27(5), 513–519. https://doi.org/10.1007/s11606-011-1930-3
  3. Alhasan, K., Aljamaan, F., Temsah, M., Alshahrani, F., Bassrawi, R., Alhaboob, A., Assiri, R., Alenezi, S., Alaraj, A., Alhomoudi, R. I., Batais, M. A., Al-Eyadhy, L., Halwani,R., AbdulMajeed, N., Al-Jedai, A., Senjab, A., Memish, Z. A., Al-Subaie, S., Barry, M., & Al-Tawfiq, J. A. (2021). COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers. Healthcare, 9(11), 1566. https://doi.org/10.3390/healthcare9111566
  4. Al-Qerem, W., Bawab, A. Q. A., Hammad, A., Ling, J., & Alasmari, F. (2022). Willingness of the Jordanian population to receive a COVID-19 booster dose: a Cross-Sectional study. Vaccines, 10(3), 410. https://doi.org/10.3390/vaccines10030410
  5. Arbel, R., Hammerman, A., Sergienko, R., Friger, M., Peretz, A., Netzer, D., & Yaron, S. (2021). BNT162b2 vaccine booster and mortality due to COVID-19. New England Journal of Medicine, 385(26), 2413–2420. https://doi.org/10.1056/nejmoa2115624
  6. Atwell, J. E., Lutz, C. S., Sparrow, E. G., & Feikin, D. R. (2022). Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries. Vaccine, 40(32), 4361–4370. https://doi.org/10.1016/j.vaccine.2022.06.034
  7. Australian Government - Department of Health and Aged Care. (2022, May 10). Is it true? Do COVID-19 vaccines contain a microchip or any kind of tracking technology? Retrieved from https://www.health.gov.au/our-work/covid-19-vaccines/is-it-true/is-it-true-do-covid-19-vaccines-contain-a-microchip-or-any-kind-of-tracking-technology
  8. Babicki, M., & Mastalerz-Migas, A. (2022). Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland. Vaccines, 10(1), 68. https://doi.org/10.3390/vaccines10010068
  9. Boukhobza, S., Ritschl, V., Stamm, T., & Bekes, K. (2021). The COVID-19 pandemic and its impact on knowledge, perception and attitudes of dentistry students in Austria: a Cross-Sectional survey. Journal of Multidisciplinary Healthcare, Volume 14, 1413–1422. https://doi.org/10.2147/jmdh.s311535
  10. Burrowes, S. a. B., Casey, S. M., Dobbins, S., Hall, T., Ma, M., Bano, R., Drainoni, M., Schechter-Perkins, E. M., Garofalo, C., Perkins, R. B., & Pierre-Joseph, N. (2022). Healthcare workers’ perspectives on the COVID-19 vaccine and boosters for themselves, their patients, and their communities: a mixed methods study. Journal of Public Health, 32(1), 123–136. https://doi.org/10.1007/s10389-022-01793-1
  11. Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C., & Winter, K. (2021). Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021. MMWR Morbidity and Mortality Weekly Report, 70(32), 1081–1083. https://doi.org/10.15585/mmwr.mm7032e1
  12. Clark-Carter, D. (2010). Measures of central tendency. In Elsevier eBooks (pp. 264–266). https://doi.org/10.1016/b978-0-08-044894-7.01343-9
  13. Creswell, J. W. (2013). Research design: Qualitative, quantitative, and mixed methods approaches. Retrieved June 5, 2022, from https://lib- guides.letu.edu/quantresearch
  14. Dadras, O., Alinaghi, S. a. S., Karimi, A., MohsseniPour, M., Barzegary, A., Vahedi, F., Pashaei, Z., Mirzapour, P., Fakhfouri, A., Zargari, G., Saeidi, S., Mojdeganlou, H., Badri, H., Qaderi, K., Behnezhad, F., & Mehraeen, E. (2021). Effects of COVID-19 prevention procedures on other common infections: a systematic review. European Journal of Medical Research, 26(1). https://doi.org/10.1186/s40001-021-00539-1
  15. Dawson, B. (2021, July 18). 20% of Americans believe the conspiracy theory that microchips are inside the COVID-19 vaccines, says YouGov study. Business Insider. https://www.businessinsider.com/20-of-americans-believe-microchips-in-covid-19-vaccines-yougov-2021-7
  16. De Giorgio, A., Kuvačić, G., Maleš, D., Vecchio, I., Tornali, C., Ishac, W., Ramaci, T., Barattucci, M., & Milavić, B. (2022). Willingness to Receive COVID-19 Booster Vaccine: Associations between Green-Pass, Social Media Information, Anti-Vax Beliefs, and Emotional Balance. Vaccines, 10(3), 481. https://doi.org/10.3390/vaccines10030481
  17. De Villa, K. (2022, April 14). Amid push for boosters, many in PH still fear ‘side effects’ | Inquirer News. INQUIRER.net. https://newsinfo.inquirer.net/1582779/amid-push-for-boosters-many-in-ph-still-fearing-side-effects
  18. Defendi, H. G. T., Da Silva Madeira, L., & Borschiver, S. (2021). Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments. Journal of Pharmaceutical Innovation, 17(2), 555–571. https://doi.org/10.1007/s12247-021-09535-8
  19. Ducharme, J. (2020, March 11). World Health Organization declares COVID-19 a ‘Pandemic.’ Here’s what that means. TIME. https://time.com/5791661/who-coronavirus-pandemic-declaration/
  20. Evans, R. (2020, January 31). An Introduction to T-Tests. Retrieved June 13, 2022, from https://www.scribbr.com/statistics/t-test/
  21. Farhat, M., Al-Ibrahim, R., Almohammedali, A., Aljishi, R., & Alalwan, B. (2022). Study of the side effects of Pfizer and Oxford COVID-19 vaccines in the eastern province of Saudi Arabia. International Journal of General Medicine, Volume 15, 7547–7558. https://doi.org/10.2147/ijgm.s379204
  22. Folcarelli, L., Del Giudice, G. M., Corea, F., & Angelillo, I. F. (2022). Intention to receive the COVID-19 vaccine booster dose in a university community in Italy. Vaccines, 10(2), 146. https://doi.org/10.3390/vaccines10020146
  23. Frederiksen, L. S. F., Zhang, Y., Foged, C., & Thakur, A. (2020). The long road Toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01817
  24. Freeman, D., Lambe, S., Yu, L., Freeman, J., Chadwick, A., Vaccari, C., Waite, F., Rosebrock, L., Petit, A., Vanderslott, S., Lewandowsky, S., Larkin, M., Innocenti, S., McShane, H., Pollard, A. J., & Loe, B. S. (2021). Injection fears and COVID-19 vaccine hesitancy. Psychological Medicine, 53(4), 1185–1195. https://doi.org/10.1017/s0033291721002609
  25. Rosenblum, H. G., Wallace, M., Godfrey, M., Roper, L. E., Hall, E., Fleming-Dutra, K. E., Link-Gelles, R., Pilishvili, T., Williams, J., Moulia, D. L., Brooks, O., Talbot, H. K., Lee, G. M., Bell, B. P., Daley, M. F., Meyer, S., Oliver, S. E., & Twentyman, E. (2022). Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022. MMWR Morbidity and Mortality Weekly Report, 71(45), 1436–1441. https://doi.org/10.15585/mmwr.mm7145a2
  26. Girum, T., Lentiro, K., Geremew, M., Migora, B., & Shewamare, S. (2020). Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review. Tropical Medicine and Health, 48(1). https://doi.org/10.1186/s41182-020-00285-w
  27. Haldane, V., Chuah, F. L. H., Srivastava, A., Singh, S. R., Koh, G. C. H., Seng, C. K., & Legido-Quigley, H. (2019). Community participation in health services development, implementation, and evaluation: A systematic review of empowerment, health, community, and process outcomes. PLoS ONE, 14(5), e0216112. https://doi.org/10.1371/journal.pone.0216112
  28. Hu, T., Li, L., Lin, C., Yang, Z., Chow, C., Lu, Z., & You, C. (2022). An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China. International Journal of Environmental Research and Public Health, 19(4), 2300. https://doi.org/10.3390/ijerph19042300
  29. John Hopkins Medicine. (2022). COVID-19 Vaccine Bivalent Update. Retrieved from https://www.hopkinsmedicine.org/coronavirus/covid-19-vaccine/
  30. Jørgensen, F. J., Nielsen, L. H., & Petersen, M. B. (2022). Willingness to take the booster vaccine in a nationally representative sample of danes. Vaccines, 10(3), 425. https://doi.org/10.3390/vaccines10030425
  31. Klobucista, C. (2022, December 6). A guide to global COVID-19 vaccine efforts. Council on Foreign Relations. https://www.cfr.org/backgrounder/guide-global-covid-19-vaccine-efforts
  32. Klugar, M., Riad, A., Mohanan, L., & Pokorná, A. (2021). COVID-19 vaccine booster hesitancy (VBH) of healthcare workers in Czechia: National Cross-Sectional Study. Vaccines, 9(12), 1437. https://doi.org/10.3390/vaccines9121437
  33. Lee, A. R. Y. B., Wong, S. Y., & Tay, S. H. (2022). Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety. Vaccines, 10(5), 668. https://doi.org/10.3390/vaccines10050668
  34. MacIntyre, C. R., Costantino, V., & Trent, M. (2021). Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia. Vaccine, 40(17), 2506–2513. https://doi.org/10.1016/j.vaccine.2021.04.042
  35. Malcom, K., & Gavin, K. (2021, September 28). Should you get a booster dose of COVID vaccine? Retrieved from https://healthblog.uofmhealth.org/wellness-prevention/should-you-get-a-third-dose-of-covid-vaccine
  36. Martínez-Córdoba, P., Benito, B., & García-Sánchez, I. (2021). Efficiency in the governance of the Covid-19 pandemic: political and territorial factors. Globalization and Health, 17(1). https://doi.org/10.1186/s12992-021-00759-4
  37. Mascarenhas, A. K., Lucia, V. C., Kelekar, A., & Afonso, N. M. (2021). Dental students’ attitudes and hesitancy toward COVID‐19 vaccine. Journal of Dental Education, 85(9), 1504–1510. https://doi.org/10.1002/jdd.12632
  38. Memorial Sloan Kettering Cancer Center. (2022, August 8). COVID-19 Vaccine Side Effects: Why They Happen and How to Treat Them. Retrieved from mskcc.org: https://www.mskcc.org/coronavirus/second-dose-covid-19-vaccine-side-effects-why-they-happen-how-treat-them?fbclid=IwAR1V7W4Wm2QsnrD2uTTrlgGAzpEhppHApA41eY_GK4gPo3PuZIUWBPrFzms
  39. Menni, C., Klaser, K., May, A., Polidori, L., Capdevila, J., Louca, P., Sudre, C. H., Nguyen, L. H., Drew, D. A., Merino, J., Hu, C., Selvachandran, S., Antonelli, M., Murray, B., Canas, L. S., Molteni, E., Graham, M. S., Modat, M., Joshi, A. D., . . . Spector, T. D. (2021). Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. The Lancet Infectious Diseases, 21(7), 939–949. https://doi.org/10.1016/s1473-3099(21)00224-3
  40. Moeed, A., Najeeb, H., Saleem, A., Asghar, M. S., Rafi, H. M., Khattak, A. K., Bilal, Z., & Seboka, B. T. (2022b). Willingness and perceptions regarding COVID-19 vaccine booster dose in Pakistani vaccinated population: A Cross-Sectional survey. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.911518
  41. Mulder, J., & De Bruijne, M. (2019). Willingness of online respondents to participate in alternative modes of data collection. Survey Practice, 12(1), 1–11. https://doi.org/10.29115/sp-2019-0001
  42. Nassani, M. Z., Noushad, M., Rastam, S., Hussain, M., Alsalhani, A. B., Al-Saqqaf, I. S., Alali, F. M., Demachkia, A. M., De Melo, R. M., Arshad, M., Luddin, N., Husein, A., Qamar, Z., Koppolu, P., Darwish, M., Nassar, A. S. A., Habib, A., Suleyman, F., Khanam, H. M. K., . . . Tarakji, B. (2022). Determinants of COVID-19 Vaccine Acceptance among Dental Professionals: A Multi-Country Survey. Vaccines, 10(10), 1614. https://doi.org/10.3390/vaccines10101614
  43. Nealon, B. D. (2021, December 6). Breaking down boosters. Harvard Medical School. https://hms.harvard.edu/news/breaking-down-boosters
  44. O’Brien, N., Flott, K., Bray, O. et al. Implementation of initiatives designed to improve healthcare worker health and wellbeing during the COVID-19 pandemic: comparative case studies from 13 healthcare provider organisations globally. Global Health 18, 24 (2022). https://doi.org/10.1186/s12992-022-00818-4
  45. Pajayon-Berse, P. P. (2022, March 17). Beyond their numbers: The youth vote, their concerns and aspirations. BusinessWorld Online. https://www.bworldonline.com/opinion/2022/03/07/434345/beyond-their-numbers-the-youth-vote-their-concerns-and-aspirations/
  46. Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., Bailey, R., Swanson, K. A., Roychoudhury, S., Koury, K., Li, P., Kalina, W. V., Cooper, D., Frenck, R. W., Jr, Hammitt, L. L., Türeci, Ö., … C4591001 Clinical Trial Group (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The New England journal of medicine, 383(27), 2603–2615. https://doi.org/10.1056/NEJMoa2034577
  47. Romero-Brufau, S., Chopra, A., Ryu, A. J., Gel, E., Raskar, R., Kremers, W., Anderson, K. S., Subramanian, J., Krishnamurthy, B., Singh, A., Pasupathy, K., Dong, Y., O’Horo, J. C., Wilson, W. R., Mitchell, O., & Kingsley, T. C. (2021). Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent-based modeling study. BMJ (Clinical research ed.), 373, n1087. https://doi.org/10.1136/bmj.n1087
  48. Ronchini, C., Gandini, S., Pasqualato, S., Mazzarella, L., Facciotti, F., Mapelli, M., Frige, G., Passerini, R., Pase, L., Capizzi, S., Mastrilli, F., Orecchia, R., Natoli, G., & Pelicci, P. G. (2022). Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs. PLoS ONE, 17(1), e0263014. https://doi.org/10.1371/journal.pone.0263014
  49. Rzymski, P., Poniedziałek, B., & Fal, A. (2021). Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines, 9(11), 1286. https://doi.org/10.3390/vaccines9111286
  50. Samuel, S. (2021, July 7). 7 questions about Covid-19 booster shots, answered. Retrieved June 20, 2022, from https://www.vox.com/future-perfect/22555898/covid-19-booster-shots
  51. Schmidt, J., Vavrickova, L., Micopulos, C., Suchanek, J., Pilbauerova, N., Perina, V., & Kapitan, M. (2022). COVID-19 among Czech Dentistry Students: Higher Vaccination and Lower Prevalence Compared to General Population Counterparts. Vaccines, 10(11), 1927. https://doi.org/10.3390/vaccines10111927
  52. Sreenivas, S. (2022, January 28). What Are Booster Shots. Retrieved from WebMD: https://www.webmd.com/vaccines/vaccine-booster-shots
  53. Sun, Y., Dai, H., Wang, P., Zhang, X., Cui, D., Huang, Y., Zhang, J., & Xiang, T. (2022). Will people accept a third booster dose of the COVID-19 vaccine? a Cross-Sectional study in China. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.914950
  54. Wong, L. P., Alias, H., Siaw, Y., Muslimin, M., Lai, L. L., Lin, Y., & Hu, Z. (2022). Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia. Human Vaccines & Immunotherapeutics, 18(5). https://doi.org/10.1080/21645515.2022.2078634
  55. World Health Organization [WHO]. (2022, April 13). COVID-19 advice for the public: Getting vaccinated. Retrieved August 14, 2022, fro https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid- 19-vaccines/advice
  56. Yetman, D. (2022, April 4). Comorbidity: Causes and Health Implications. Retrieved from https://www.healthline.com/health/comorbidity
  57. Yu, Y., Esposito, D., Kang, Z., Lu, J., Remaley, A. T., De Giorgi, V., Chen, L. N., West, K., & Cao, L. (2022). mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-06629-2.
  58. Zachreson, C., Chang, S. L., Cliff, O. M., & Prokopenko, M. (2021). How will mass-vaccination change COVID-19 lockdown requirements in Australia? The Lancet Regional Health - Western Pacific, 14, 100224. https://doi.org/10.1016/j.lanwpc.2021.100224

Tools


Copyright © 2026  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic